See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2024_Lixte_Biotechnology_Holdings_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001335105, Lixte Biotechnology Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,308,620 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 313,858 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,906,999 |
| 9 | ResearchAndDevelopmentExpense | 847,720 |
| 10 | remainder_Expenses | 2,478,185 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 15,469 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,308,620 |
| 1 | Liabilities | 313,858 |
| 2 | Expenses | 5,232,904 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,994,762 |
| 5 | NetIncome | -5,217,435 |
| 6 | ComprehensiveNetIncome | -5,217,435 |
| 7 | BaseVar | 4,935,426 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.51 |
| 9 | EconomicCapitalRatio | 2.69 |